ITI Pharma and Healthcare Fund - Regular Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 18.4005 ↑ 1.06%
[as on 21 September, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option and its peers as on 21 September, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 17.63% 1.06% 1.81% 2.52% 9.4% 11.01% 18.93%---
SBI MNC FUND - REGULAR PLAN -GROWTH 15.78% -0.12% -0.47% -1.56% 5.03% 12.7% 7.12% 7.63% 13.32% 10.85%
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 25.27% 0.72% 0.83% 2.27% 10.65% 20.3% 23.74% 17.72% 24.67% 13.63%
SBI COMMA Fund - REGULAR PLAN - Growth 4.73% -0.6% -1.23% -1.24% 0.25% 8.38% 15.47% 10.36% 18.85% 14.59%
SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth -5.48% -0.07% -0.01% -3.53% -1.06% -3.77% 8.02% 7.29% 11.93% 10.74%
SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH -0.39% 0.04% -0.68% -2.49% -4.34% 0.65% 12.68% 15.14% 18.55% 14.41%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns------ -8.89% 32.42% 41.76% -10.78%

Discrete returns (monthly)

MonthNov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026
Returns -1.19% -2.59% -6.96% 6.8% -4.76% 7.57% 2.95% 5.81% 3.87% 2.74%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 4.38%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
97.89% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 2.11%

Equity

NameSymbol / ISINSectorWeight %Other links
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology13.26%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology7.97%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services6.05%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.05%
Torrent Pharmaceuticals LimitedTORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology4.84%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology4.43%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology4.41%
Laurus Labs LimitedLAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology4.21%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology3.84%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology3.39%
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology3.04%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology3.03%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services2.98%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.92%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology2.82%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services2.79%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology1.90%
Poly Medicure LimitedPOLYMED (INE205C01021)Healthcare Equipment & Supplies1.52%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.50%
Aster DM Quality Care LimitedASTERDM (INE914M01019)Healthcare Services1.35%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.32%
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology1.27%
Shaily Engineering Plastics LimitedSHAILY (INE151G01028)Consumer Durables1.23%
Healthcare Global Enterprises LimitedHCG (INE075I01017)Healthcare Services1.21%
Shilpa Medicare LimitedSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology1.15%
Linde India LimitedLINDEINDIA (INE473A01011)Chemicals & Petrochemicals1.10%
Glenmark Pharmaceuticals LimitedGLENMARK (INE935A01035)Pharmaceuticals & Biotechnology1.09%
Rainbow Childrens Medicare LimitedRAINBOW (INE961O01016)Healthcare Services1.05%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology0.95%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology0.93%
Supriya Lifescience LimitedSUPRIYA (INE07RO01027)Pharmaceuticals & Biotechnology0.92%
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing0.88%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology0.72%
Venus Pipes And Tubes LimitedVENUSPIPES (INE0JA001018)Industrial Products0.69%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.61%
Caplin Point Laboratories LimitedCAPLIPOINT (INE475E01026)Pharmaceuticals & Biotechnology0.54%
Bharat Dynamics LimitedBDL (INE171Z01026)Aerospace & Defense0.47%
Yes Bank LimitedYESBANK (INE528G01035)Banks0.46%

Debt

NameRatingWeight %
Portfolio data is as on date 31 July, 2026

NAV history

ITI Pharma and Healthcare Fund - Regular Plan - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
21 September, 202618.4005 1.06%
18 September, 202618.2069 0.95%
17 September, 202618.0364 1.45%
16 September, 202617.7783 -0.15%
15 September, 202617.8053 -1.48%
11 September, 202618.0725 -0.31%
10 September, 202618.1286 -0.46%
9 September, 202618.2127 -0.25%
8 September, 202618.2591 0.82%
7 September, 202618.1098 0.39%
4 September, 202618.0390 -0.62%
3 September, 202618.1512 -0.19%
2 September, 202618.1854 -0.09%
1 September, 202618.2022 -1.26%
31 August, 202618.4347 0.87%
28 August, 202618.2748 0.24%
27 August, 202618.2303 0.59%
26 August, 202618.1238 0.39%
25 August, 202618.0538 0.8%
24 August, 202617.9108 -0.21%
21 August, 202617.9481 -0.43%
20 August, 202618.0249 0.31%
19 August, 202617.9694 -0.34%
18 August, 202618.0301 0.38%
17 August, 202617.9611 -0.37%
14 August, 202618.0274 -0.32%
13 August, 202618.0850 -0.23%
12 August, 202618.1271 -0.81%
11 August, 202618.2753 0.46%
10 August, 202618.1920

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
    The latest NAV of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option is 18.4005 as on 21 September, 2026.
  • What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
    The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 17.63% as on 21 September, 2026.
  • What are 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
    The 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 11.01% as on 21 September, 2026.
  • What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
    The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 18.93% as on 21 September, 2026.
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
    ITI Pharma and Healthcare Fund - Regular Plan - Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.